2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Unknown
2
Sponsor Class
OTHER
26
NIH
3
INDUSTRY
2
FED
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Barrett Esophagus
2
Adenocarcinoma Of Esophagus
1
Interventions
pembrolizumab
1029
Carboplatin
966
Paclitaxel
941
Gemcitabine
798
Cisplatin
754
Docetaxel
697
Bevacizumab
638
Nivolumab
519
Pemetrexed
507
Capecitabine
475
Cyclophosphamide
468
Fluorouracil
424
Dexamethasone
409
Rituximab
391
Oxaliplatin
351
Injections
344
Trastuzumab
313
atezolizumab
311
Cetuximab
291
Leucovorin
288
Irinotecan
269
130-nm albumin-bound paclitaxel
255
Prednisone
250
Ipilimumab
244
Doxorubicin
241
Lenalidomide
231
Fulvestrant
226
fludarabine
215
durvalumab
211
Erlotinib Hydrochloride
196
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Endoscopy, Digestive System
×
Clear all
NCT04295811
2023-01-25
ESOGUARDBE2
PAVmed Inc.
Phase NA
Unknown
470 enrolled
NCT02864043
2020-03-04
DDP
NinePoint Medical
Phase NA
Unknown
150 enrolled